According to a recent report published by SNS Insider, the Blood Collection Market Size was valued at USD 3.39 billion in 2023 and is expected to grow significantly, reaching USD 7.25 billion by 2032. This represents a robust compound annual growth rate (CAGR) of 8.84% over the forecast period from 2024 to 2032.
The increasing prevalence of chronic and infectious diseases, coupled with the growing number of surgical procedures and diagnostic tests, is fueling demand for efficient and safe blood collection technologies. Moreover, advancements in blood collection devices, including vacuum-based collection tubes and safety-engineered needles, are enhancing patient comfort and reducing the risk of contamination and needlestick injuries.
Rising Healthcare Needs and Awareness Spur Market Demand
Healthcare providers across the globe are prioritizing accurate diagnostic tools, including blood tests, as early disease detection becomes critical in minimizing treatment costs and improving patient outcomes. The surge in lifestyle diseases like diabetes, hypertension, and cardiovascular disorders has amplified the need for regular blood testing. Consequently, hospitals, diagnostic laboratories, and blood banks are increasingly investing in modern blood collection systems that ensure sample integrity and safety.
Emerging economies are also seeing a rise in government healthcare spending and infrastructure upgrades, creating significant opportunities for market penetration. Public awareness campaigns around blood donation and the growing popularity of preventive healthcare have also added momentum to market growth.
Market Segmentation Highlights
The blood collection market is segmented by product type, method, application, and end-user. Among products, blood collection needles and syringes hold a substantial share due to their wide usage and continual improvements in safety features. Vacuum blood collection systems are also gaining popularity, especially in high-volume diagnostic centers, because of their efficiency and reduced contamination risk.
By method, manual blood collection remains dominant; however, automated systems are catching up due to their enhanced precision and reduced operator dependency. In terms of application, diagnostics represent the largest share, followed by therapeutic uses and donations.
North America Leads, But Asia-Pacific Emerging as Fastest-Growing Region
North America accounted for the largest market share in 2023, thanks to its advanced healthcare infrastructure, high patient awareness levels, and established diagnostic networks. The region's stringent safety regulations have also promoted the adoption of innovative blood collection devices.
Meanwhile, the Asia-Pacific region is projected to witness the fastest growth during the forecast period. Factors contributing to this include rapid urbanization, rising healthcare expenditure, increasing incidence of chronic diseases, and growing medical tourism in countries like India, China, and South Korea.
Key Players and Strategic Developments
Major companies operating in the blood collection market are actively pursuing strategic initiatives such as mergers, acquisitions, collaborations, and product launches to strengthen their market presence. Key players include Becton, Dickinson and Company, Terumo Corporation, Greiner Bio-One, Medtronic, Quest Diagnostics, and others. These companies are focused on innovations like needleless systems, improved ergonomics, and eco-friendly collection materials to meet evolving consumer needs and regulatory expectations.
Recent developments include:
- Becton, Dickinson and Company launching a new safety-engineered blood collection set to minimize accidental exposures.
- Greiner Bio-One expanding its product portfolio with user-friendly vacuum collection tubes adapted for pediatric use.
- Terumo Corporation increasing its investment in emerging markets to establish manufacturing and distribution centers.
Future Outlook
As the global emphasis on preventive healthcare and early disease detection continues to grow, the demand for blood collection tools will remain strong. Continuous technological innovations, rising healthcare expenditure, and improved access to diagnostic services—especially in developing countries—are poised to propel the blood collection market to new heights. Industry players who invest in sustainable, safe, and user-friendly collection technologies will be well-positioned to capitalize on the market’s future growth trajectory.
About Us:
SNS Insider is one of the leading market research and consulting agencies that dominates the market research industry globally. Our company's aim is to give clients the knowledge they require in order to function in changing circumstances. In order to give you current, accurate market data, consumer insights, and opinions so that you can make decisions with confidence, we employ a variety of techniques, including surveys, video talks, and focus groups around the world.
Contact Us:
Akash Anand – Head of Business Development & Strategy
📧 info@snsinsider.com
📞 +1-415-230-0044 (US) | +91-7798602273 (IND)
Other Trending Reports